37 Similarly, in a retrospective cohort study of 3435 people with type 2 diabetes exposed to tirzepatide for 180 days and over compared with a matched unexposed cohort, tirzepatide was associated with an increased risk of new-onset proliferative diabetic retinopathy primarily in those with pre-existing nonproliferative diabetic retinopathy
Long-term safety data spanning up to 12 months of continuous use shows no significant accumulation of adverse effects or development of tolerance
But with high demand and periodic shortages, many patients turned to oral compounded Tirzepatide and oral compounded Semaglutide as alternatives
People with a history of pancreatitis, gallstones, or heavy alcohol use or anyone switching from one GLP-1 medication to another without proper dosage adjustment may be at greater risk of pancreatitis on GLP-1s
Immunomodulatory effects of selank in patients with anxiety-asthenic disorders
Our expertise With over 15 years of career experience in life and safety sciences, our team translates discipline into quality you can trust
